ACCURAY INC

For the period ended Jun 30, 2024. Filed Sep 19, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Sep 19, 2024

ARAY$3.82Day change unavailableStored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(in thousands, except share and per share amounts)

June 30, 2024 · June 30, 2023
ASSETS
Current assets:
Cash and cash equivalents	$68,570		$89,402
Restricted cash	485		524
Accounts receivable, net of allowance for credit losses of $2,251 and $3,079 as of June 30, 2024 and June 30, 2023, respectively (a)	92,001		74,777
Inventories	138,324		145,150
Prepaid expenses and other current assets (b)	23,006		27,612
Deferred cost of revenue	850		568
Total current assets	323,236		338,033
Property and equipment, net	24,774		20,926
Investment in joint venture	9,826		15,128
Operating lease right-of-use assets, net	33,773		25,853
Goodwill	57,672		57,681
Intangible assets, net	59		210
Restricted cash	1,337		1,276
Other assets	17,950		20,107
Total assets	$468,627		$479,214
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$50,020		$33,739
Accrued compensation	17,128		23,793
Operating lease liabilities	6,218		4,151
Other accrued liabilities	28,508		38,271
Customer advances	13,988		20,777
Deferred revenue	71,649		72,185
Short-term debt, net of unamortized debt costs	7,756		5,721
Total current liabilities	195,267		198,637
Long-term liabilities:
Operating lease liabilities	32,373		23,602
Long-term other liabilities	7,389		4,675
Deferred revenue	24,114		27,079
Long-term debt, net of unamortized debt costs	164,400		171,562
Total liabilities	423,543		425,555
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, $0.001 par value; authorized: 5,000,000 shares; no shares issued and outstanding		—
Common stock, $0.001 par value; authorized: 200,000,000 shares as of June 30, 2024 and June 30, 2023, respectively; issued and outstanding: 100,194,932 and 96,534,609 shares at June 30, 2024 and June 30, 2023, respectively	100		97
Additional paid-in-capital	566,887		555,276
Accumulated other comprehensive income (loss)	(4,222)		422
Accumulated deficit	(517,681)		(502,136)
Total stockholders' equity	45,084		53,659
Total liabilities and stockholders’ equity	$468,627		$479,214

(a)

Included accounts receivable from the joint venture, an equity method investment, of $25,339 and$10,304 at June 30, 2024, and June 30, 2023, respectively. See Note 11.

(b)

Included other receivable from the joint venture, an equity method investment, of$743 and$100 at June 30, 2024, and June 30, 2023, respectively.

The accompanying notes are an integral part of these consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.